| scholarly article | Q13442814 |
| P356 | DOI | 10.1634/STEMCELLS.2007-0321 |
| P8608 | Fatcat ID | release_7lktwjdb2rd75jwi4kpe67s37a |
| P698 | PubMed publication ID | 17690179 |
| P50 | author | Toyomasa Katagiri | Q114328235 |
| P2093 | author name string | Yasuharu Nishimura | |
| Yusuke Nakamura | |||
| Satoru Senju | |||
| Hirofumi Suemori | |||
| Norio Nakatsuji | |||
| Manami Shimomura | |||
| Miwa Haruta | |||
| Shinya Hirata | |||
| Yasushi Uemura | |||
| Satoshi Fukushima | |||
| Hitoshi Zembutsu | |||
| Daiki Fukuma | |||
| Hidetake Matsuyoshi | |||
| Masataka Furuya | |||
| Yusuke Matsunaga | |||
| P2860 | cites work | Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs. | Q30879100 |
| Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway | Q40313182 | ||
| Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. | Q40460778 | ||
| Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination | Q40602136 | ||
| Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. | Q51088950 | ||
| P433 | issue | 11 | |
| P921 | main subject | dendritic cell | Q506253 |
| human embryonic stem cell | Q59626782 | ||
| P304 | page(s) | 2720-2729 | |
| P577 | publication date | 2007-08-09 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function | |
| P478 | volume | 25 |
| Q36168490 | Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells |
| Q37742101 | Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies |
| Q39856765 | Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells |
| Q33912582 | Characterization of full-length MHC class II sequences in Indonesian and Vietnamese cynomolgus macaques |
| Q38453644 | Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy |
| Q39303869 | Differentiation and characterization of dendritic cells from human embryonic stem cells |
| Q44203775 | Dual Effects of TRAIL in Suppression of Autoimmunity: The Inhibition of Th1 Cells and the Promotion of Regulatory T Cells |
| Q33659579 | Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome. |
| Q39571768 | Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy |
| Q53503551 | Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. |
| Q42395107 | Generation of induced pluripotent stem cells from mouse cancer cells. |
| Q37328520 | Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors |
| Q34732161 | Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells |
| Q39051569 | Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response |
| Q27314152 | Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics |
| Q48222588 | Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3. |
| Q37861025 | Immunotherapy with pluripotent stem cell-derived dendritic cells |
| Q84529622 | Interleukin-4 enhances trafficking and functional activities of GM-CSF-stimulated mouse myeloid-derived dendritic cells at late differentiation stage |
| Q51043236 | Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. |
| Q39547016 | Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency |
| Q37692223 | Pluripotent stem cells as source of dendritic cells for immune therapy |
| Q39364261 | Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype |
| Q34734082 | Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells |
| Q34292924 | TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells |
| Q37398305 | Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. |
Search more.